Ajooni Biotech Limited — Major Shareholding Notification 2025

Dec 31, 2025

31/12/2025

To, Manager - Listing Compliance National Stock Exchange of India Limited 'Exchange Plaza'. C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Dear Sir/Madam,

SYMBOL-AJOONI

ISIN: INE820Y01021

Subject: Disclosure under Regulation 10(6) of SEBI (SAST) Regulations, 2011 regarding Inter-se Transfer of shares amongst Promoters through an Off Market transaction

Dear Sir/Madam,

In compliance with the provisions of Regulation 10 (1) (a)(ii) read with Regulation 10 (5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we hereby submit the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in regards to the proposed acquisition of Equity Shares of Ajooni Biotech Limited as inter-se transfer of shares through an off market transaction.

Kindly find attached requisite disclosure under Regulation 10(6) of SEBI (SAST) Regulations, 2011 and take the same on your records and acknowledge the same.

Thanking You,

Yours Truly,

$770 + 166$

Jasjot Singh Acquirer

Place: Mohali

Encl: As above. CC: Ajooni Biotech Limited

Parmjest Kauer

Acquirer

Format for Disclosures under Regulation 10(6) -Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1. Name of the Target Company (TC)	AJOONI BIOTECH LIMITED
2. Name of the acquirer(s)	JASJOT SINGH PARMJEET KAUR 2.
3. Name of the stock exchange where shares of the TC are listed	NSE
4. Details of the transaction including rationale, if any, for the transfer/ acquisition of shares.	Inter-se transfer of shares amongst promoters of the Company
5. Relevant regulation under which the acquirer is exempted from making open offer.	Regulation 10 (1) (a) (ii) of SEBI SAST Regulations
6. Whether disclosure of proposed YES regulation $10(5)$ and if so, - whether disclosure was made and Date: 23/12/2025 whether it was made within the timeline specified under the regulations. - date of filing with the stock exchange.	acquisition was required to be made under Disclosure was made within the timeline specified under the regulations.
7. Details of acquisition	Disclosures required to be made under regulation $10(5)$	Whether the disclosures under regulation $10(5)$ are actually made
Name of the transferor / seller a.	As per Annexure-1	YES
Date of acquisition b.	On or after 30th December 2025, Tuesday	23/12/2025
Number of shares/voting rights in C. respect of the acquisitions from each person mentioned in 7(a) above	As per Annexure-1	As per Annexure-1
Total shares proposed to be acquired / actually acquired as a % of diluted share capital of TC	As per Annexure-1	As per Annexure-1
Price at which shares are proposed to е. be acquired / actually acquired	@ Rs. 4.20/- each (for each acquirer)	Yes

$\Lambda^{opt}$ deh

Prompert Fau

8.	Shareholding details		Pre-Transaction		Post-Transaction
			of No. shares held	% w.r.t total share capital of TC	No. of shares held	% w.r.t total share capital of TC
	$\mathbf{a}$	Each Acquirer / Transferee(*)
		Jasjot Singh	1,89,68,521	11.01	2,89,68,521	16.81
		Parmjeet Kaur	56,78,802	3.3	77,90,976	4.52
	b	Each Seller / Transferor
		Healthy Biosciences Limited	1,21,12,174	7.03		0.00

Note:

• (*) Shareholding of each entity shall be shown separately and then collectively in a ۰ group.
• The above disclosure shall be signed by the acquirer mentioning date & place. In case, $\bullet$ there is more than one acquirer, the report shall be signed either by all the persons or

by a person duly authorized to do so on behalf of all the acquirers.

$-170 + 184$

Jasjot Singh Acquirer

Date: 31/12/2025 Place: Mohali

Parmjest Kauel Acquirer

Annexure-1

Details of proposed Acquisition of Shares of Target Company

S.No.	Name of the Seller	Name of the Acquirer	Disclosures required to be made under regulation $10(5)$		Disclosures under regulation 10(5) are actually made
			Maximum no.of shares of TC to be acquired	Y o age of total shares of TC	No. of shares of TC acquired	%age of total shares of TC	Price Per share (Rs.)
1.	Healthy Bioscience s Limited	Jasjot Singh	1,00,00,000	5.8%	1,00,00,000	5.8%	4.20
2.	Healthy Bioscience s Limited	Parmjeet Kaur	21, 12, 174	1.23%	21, 12, 174	1.23%	4.20
	TOTAL		1,21,12,174	7.03%	1.21.12.174	7.03%

Transfer

Jasjot Singh

Acquirer

Parmjeut Kaur

Acquirer